Text Size

Effectiveness of Assertive Continuing Care for Youth

This study has been completed.
Sponsor:
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by:
Chestnut Health Systems
ClinicalTrials.gov Identifier:
NCT01085188
First received: March 10, 2010
Last updated: NA
Last verified: March 2010
History: No changes posted
  Purpose

Following discharge from residential treatment 324 adolescents are randomly assigned to Assertive Continuing Care with and without motivational incentives in a 2 x 2 factorial design. Clinical outcomes are assessed at 3, 6, 9, and 12 months post discharge.


Condition Intervention Phase
Substance Use Disorders
 Behavioral: ACC
Behavioral: CM
Behavioral: UCC
 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Primary Purpose: Treatment

Further study details as provided by Chestnut Health Systems:

Enrollment: 342
Study Start Date: January 2003
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Assertive Continuing Care (ACC)
Behavioral intervention comprised of the community reinforcement approach plus case management delivered in home and other community settings to youth and their caregivers.
 Behavioral: ACC
Weekly community based behavioral counseling and case management
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Experimental: Contingency Management (CM)
Using a prize drawing system (no, low, medium and large value prizes) with adolescents could earn escalating prize drawing opportunities by completing verifiable pro-social activities and providing negative urine test and breath alcohol test results.
 Behavioral: CM
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Experimental: ACC + CM
This arm is the combination of arms 1 and 2.
 Behavioral: ACC
Weekly community based behavioral counseling and case management
Behavioral: CM
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
Active Comparator: Usual Continuing Care (UCC)
UCC consists of a discharge recommendation to seek aftercare services at nearest treatment provider to where the patient lived. This service primarily consisted of outpatient group counseling.
 Behavioral: UCC
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.

  Eligibility

Ages Eligible for Study:   12 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Met DSM-IV diagnostic criteria for abuse or dependence on alcohol or another drug in the past year
  • Been between the ages of 12 and 18 at the time of residential admission; and (c) resided in one of ten Illinois counties targeted for the intervention

Exclusion Criteria:

  • left residential treatment prior to the seventh day
  • did not return to a target county at discharge
  • showed evidence of cognitive impairment that interfered with understanding of study instruments, procedures, or the informed consent process
  • were deemed dangerous to themselves or others during treatment
  • were a ward of child protective services and inaccessible for the intervention
  • met DSM-IV criteria for pathological gambling
  • were discharged to the state department of corrections
  • were already participating in a treatment study
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Mark D. Godley, Ph.D./Director of Research and Development, Chestnut Health Systems
ClinicalTrials.gov Identifier: NCT01085188     History of Changes
Other Study ID Numbers: 1018-1201
Study First Received: March 10, 2010
Last Updated: March 10, 2010
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 18, 2013